Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences TDF/TAF product liability litigation by Year
TDF/TAF product liability litigation — California coordinated proceeding plaintiffs (count)
Gilead Sciences TDF/TAF product liability litigation: 2,470 in FY2025, unchanged from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-K Note 12 Commitments and Contingencies.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | TDF/TAF product liability litigation — California coordinated proceeding plaintiffs (count) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,470 | 0.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 2,470 | – | Form 10-K (filed 2025-02-28) ↗ |
Cite this data
StockData. (2026). Gilead Sciences TDF/TAF product liability litigation, annual FY2024–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/lit-plaintiffs-ca
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.